title: A promising target for treatment of multidrug-resistant bacterial infections.
authors.forename: Martin S
authors.initials: MS
authors.lastname: Davey
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Tyrrell
authors.forename: Robin A
authors.initials: RA
authors.lastname: Howe
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Walsh
authors.forename: Bernhard
authors.initials: B
authors.lastname: Moser
authors.forename: Mark A
authors.initials: MA
authors.lastname: Toleman
authors.forename: Matthias
authors.initials: M
authors.lastname: Eberl
mesh_terms: D045247:Chryseobacterium / Q000187:drug effects / Q000378:metabolism; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects*; D016972:Enterobacter cloacae / Q000187:drug effects / Q000378:metabolism; D004896:Erythritol / Q000031:analogs & derivatives / Q000378:metabolism; D004926:Escherichia coli / Q000187:drug effects / Q000378:metabolism; D005578:Fosfomycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000378:metabolism; D008826:Microbial Sensitivity Tests; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000378:metabolism; D013403:Sugar Phosphates / Q000378:metabolism; D013729:Terpenes / Q000378:metabolism
chemical_list: C114232:2-C-methylerythritol 4-phosphate; D013403:Sugar Phosphates; D013729:Terpenes; D005578:Fosfomycin; C024640:fosmidomycin; D004896:Erythritol